Strides Pharma Science is selling its Australian business Arrow Pharmaceuticals to the Arrow-Apotex merged entity in a deal worth AUD394 million (USD285 million).
PREMIUM NEWS STORY
This Premium News Story is only available to people who have a paid-for Annual Subscription to the OTCToolbox website. If you have an Annual Subscription, please click the login button below to read this Premium News Story in full.
Find out how to take out an Annual Subscription – which will give you unlimited access to all the publications on the OTCToolbox website for a whole year – by clicking the Subscribe button below.